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Experimental design 1. Sample size
Describe how sample size was determined.
As stated in the methods, all sequentially enrolled patients with ALL were included in the analysis through a specific cutoff date to ensure adequate follow up
Data exclusions
Describe any data exclusions.
No data was excluded from the analysis
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication of the pre-clinical experiments were successful
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
In the murine experiments, mice were injected with leukemia and randomly distributed (without bias from the luciferase imaging of leukemia burden) to treatment groups
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Mouse imaging was performed by an operator who was blinded to treatment group.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section) Describe the software used to analyze the data in this study.
Statistics were performed using GraphPad Prism. Details of the sequencing analysis are included in the Methods.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
There are no restrictions on availability of material described.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Antibodies used for flow cytometry are listed in Methods. Clinical samples were analyzed in CLIA laboratories at the NIH and were validated in this laboratory. Details on the site density measurement assay is included in Methods. 
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
Male and female Non-Obese Diabetic, SCID, gamma KO (NSG) mice were use for xenograft studies.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
Required information is included in supplemental table.
